Viromed Medical Wins Turkish Approval for ViroCAP med

Bitget2026/11/04 15:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Viromed Medical received Turkish approval for ViroCAP med to treat open wounds and for intraoperative use.
The clearance enables deliveries against binding minimum orders for 7,000 ViroCAP derma/med devices in Turkey through 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2428580_en) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viromed Medical Wins Turkish Approval for ViroCAP med

You may also like

Crypto prices